Renal transplantation under FK 506 in patients with previous loss of renal function due to hemolytic uremic syndrome.
McCauley
J
J
Department of Medicine, University of Pittsburgh School of Medicine, Presbyterian-University Hospital, PA 15213.
Shapiro
R
R
Bronster
O
O
Jordan
M
M
Ellis
D
D
Gilboa
N
N
Scantlebury
V
V
Jensen
C
C
Jain
A
A
Starzl
T
T
D000328:Adult; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D007223:Infant; D007668:Kidney / Q000503:physiopathology; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced; D016896:Treatment Outcome
D016572:Cyclosporine; D016559:Tacrolimus